TCL-1B5 Activators
TCL-1B5 Activators are a diverse set of chemical compounds that indirectly stimulate the functional activity of TCL-1B5 via various cellular pathways. Compounds like Forskolin and Isoproterenol exert their effects by increasing intracellular cAMP levels, which in turn activate protein kinase A (PKA). PKA phosphorylates a variety of substrates, potentially including TCL-1B5 or proteins within its signaling cascade, thereby enhancing TCL-1B5's functional activity. Similarly, Dibutyryl cAMP (db-cAMP) serves as a cAMP analog, directly activating PKA and thus, may influence TCL-1B5 activity. Phorbol 12-myristate 13-acetate (PMA) and Ionomycin directly activate protein kinase C (PKC) and increase intracellular calcium levels, respectively, both of which are capableof influencing downstream targets related to TCL-1B5. This activation of PKC or the release of calcium can lead to the phosphorylation and activation of proteins that interact with TCL-1B5, intensifying its role within the cell. Thapsigargin also raises cytosolic calcium levels by inhibiting the SERCA pump, potentially activating calcium-dependent kinases that could enhance TCL-1B5's functionality.
On the other hand, chemical inhibitors such as LY294002 and Wortmannin selectively inhibit phosphoinositide 3-kinases (PI3K), which may shift cellular signaling in favor of pathways that activate TCL-1B5 or enhance its activity. Epigallocatechin gallate (EGCG), as a kinase inhibitor, could reduce competing phosphorylation events, thereby indirectly promoting TCL-1B5's activity. Anisomycin and Staurosporine, through their effect on stress-activated protein kinases and broad-spectrum kinase inhibition, respectively, may lead to modifications in the phosphorylation status of proteins that are part of TCL-1B5's signaling network, enhancing its activity. Lastly, Calyculin A, by inhibiting protein phosphatases, could prevent the dephosphorylation of proteins associated with TCL-1B5, maintaining TCL-1B5 in an activated state. Together, these activators work through modulation of phosphorylation and secondary messenger systems to enhance the functional activity of TCL-1B5 without directly increasing its expression or requiring direct activation of the protein itself.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels, which can lead to the activation of PKA. PKA then might phosphorylate TCL-1B5 or its associated proteins, leading to an enhancement of TCL-1B5’s functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator, which can lead to the phosphorylation of proteins involved in the same signaling pathways as TCL-1B5, potentially enhancing TCL-1B5’s activity through downstream effects. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, possibly activating calcium-dependent kinases that could phosphorylate TCL-1B5 or its related signaling components, enhancing TCL-1B5's functionality. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels, which could activate kinases that enhance TCL-1B5’s activities. | ||||||
Calcium dibutyryladenosine cyclophosphate | 362-74-3 | sc-482205 | 25 mg | $147.00 | ||
db-cAMP is a cAMP analog that activates PKA. PKA may then phosphorylate substrates that could interact with TCL-1B5 or modify its activity state, thereby enhancing its function. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can increase cAMP levels in cells, leading to the activation of PKA, which may enhance TCL-1B5 activity by phosphorylating associated proteins. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit several protein kinases, which could relieve inhibitory phosphorylation on pathways involving TCL-1B5, thus potentially enhancing TCL-1B5’s function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which could shift signaling pathways towards those that activate TCL-1B5 or enhance its activity by affecting the phosphorylation status of related proteins. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases like JNK, which may lead to the phosphorylation of proteins in the TCL-1B5 signaling network, potentially enhancing TCL-1B5 activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor that could selectively activate TCL-1B5 pathways by reducing competitive inhibitory phosphorylation on TCL-1B5 or associated proteins. | ||||||